As of 01/25.1,2
THE ANYTIME, ANYWHERE MIGRAINE MEDICINE™1
QUICKLY ELIMINATES
MIGRAINE PAIN WITHIN 2 HOURS1
POWERFUL
Eliminates pain1
21% of patients experienced pain freedom at 2 hours (co-primary endpoint)*
UBRELVY® 100 mg (95/448) vs 12% placebo (54/456)1,3
RAPID
Relieves pain quickly1
61% of patients experienced pain relief at 2 hours (secondary endpoint)*
UBRELVY 100 mg (275/448) vs 49% placebo (224/456)1,4
PRODROME
Demonstrated data for treatment early in the migraine attack5
Data on patients who avoided moderate to severe headache pain, when UBRELVY 100 mg was taken during prodrome5
Data presented above is in reference to UBRELVY 100 mg only. See similar results for patients taking UBRELVY 50 mg.6
See ACHIEVE Pivotal Trials Design pop-up for more detail, including additional co-primary endpoint data.
INDICATION
UBRELVY® (ubrogepant) is indicated for the acute treatment of migraine with or without aura in adults. UBRELVY is not indicated for the preventive treatment of migraine.
Comprehensive Savings and Support
With the UBRELVY Complete Savings Card, eligible commercially insured patients may pay as little as $0† a month for UBRELVY
For Eligible Commercially Insured Patients Taking an Oral Triptan
Start your patients on UBRELVY with the UBRELVY Challenge. If they choose to refill their oral triptan, the next triptan fill is on us‡
Broad National Coverage
UBRELVY is covered for 97% of nationally commercially insured lives3§
*In pivotal clinical studies, patients took UBRELVY within 4 hours of a migraine attack.7
†Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit UBRELVYsavingscard.com or call 1-844-577-6239 for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
‡Offer not available to patients enrolled in Medicare, Medicaid, or any other federal or state healthcare programs. Restrictions, including savings maximums, apply. Patient out-of-pocket expense will vary depending on insurance coverage. UBRELVY coupon becomes valid upon activation of offer. Oral triptan medication coupon becomes valid two (2) weeks from activation of offer and expires six (6) weeks from activation of offer. For full Terms and Conditions, visit ubrelvy.com/challenge-terms or call 1-844-577-6239 for more information.
§Managed Markets Insight & Technology, LLCTM, a trademark of MMIT. Data as of August 2024 and subject to change.
Data are not a guarantee of coverage, or partial or full payment, by any payers listed. Actual benefits are determined by respective plan administrators. Insurer plans, coverage criteria, and formularies are subject to change without notice. Check each patient’s coverage with applicable insurer. AbbVie does not endorse any individual plans. Formulary coverage does not imply efficacy or safety.
No head-to-head studies have been conducted between UBRELVY and triptans; therefore, no conclusions regarding safety or efficacy can be drawn.
